Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Shares Issued (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Shares Issued for 12 consecutive years, with $228000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 93.99% to $228000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, up 33.39% year-over-year, with the annual reading at $7.2 million for FY2025, 33.39% up from the prior year.
  • Shares Issued for Q4 2025 was $228000.0 at Niagen Bioscience, up from $152000.0 in the prior quarter.
  • The five-year high for Shares Issued was $24.9 million in Q1 2021, with the low at $152000.0 in Q3 2025.
  • Average Shares Issued over 4 years is $4.7 million, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Shares Issued soared 18741.67% in 2021, then crashed 93.99% in 2025.
  • Over 4 years, Shares Issued stood at $1.9 million in 2021, then skyrocketed by 314.5% to $7.7 million in 2022, then crashed by 51.06% to $3.8 million in 2024, then plummeted by 93.99% to $228000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $228000.0, $152000.0, and $3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.